LG 101506: High-Purity RXR Modulator for Advanced Nuclear Receptor Research

Executive Summary: LG 101506 is a chemically defined RXR modulator with a molecular weight of 420.53 g/mol, enabling reproducible RXR signaling pathway experiments in chemical biology (APExBIO product page). This compound achieves 98.00% purity and offers solubility up to 42.05 mg/ml in DMSO and 21.03 mg/ml in ethanol under standard laboratory conditions (25°C). It is shipped on blue ice or dry ice to maintain stability, with recommended storage at -20°C. LG 101506 is not intended for diagnostic or therapeutic use but is a validated tool for investigating RXR's role in metabolism, cancer biology, and immune checkpoint signaling (Zhang et al., 2022). Its application advances the study of nuclear receptor-related disease models and supports translational research in immunometabolism.

Biological Rationale

RXR (Retinoid X Receptor) is a nuclear receptor that forms heterodimers with other nuclear receptors, modulating gene expression in response to endogenous and synthetic ligands. RXR signaling regulates lipid metabolism, glucose homeostasis, inflammation, and immune responses (Zhang et al., 2022). Disruption of RXR pathways is implicated in metabolic syndromes, autoimmune disorders, and cancer. RXR modulates immune checkpoints, such as PD-L1 expression, affecting T cell activation and tumor immune evasion. Thus, RXR modulators like LG 101506 are crucial for dissecting these complex signaling networks in preclinical models. This article expands on the benchmarking and translational context detailed in LG 101506: RXR Modulator Innovation by providing atomic-level experimental parameters and direct interventional evidence.

Mechanism of Action of LG 101506

LG 101506 acts as a selective modulator of RXR, binding to the ligand-binding domain of the receptor. Upon binding, it induces conformational changes that alter RXR's interaction with co-activators and co-repressors, modulating transcriptional activity of RXR-regulated genes. In heterodimeric complexes (e.g., RXR-PPAR, RXR-LXR), LG 101506 influences the recruitment of chromatin remodeling factors, thereby impacting downstream gene expression relevant to metabolism and immune regulation (see detailed chemical biology workflow). Unlike classical RXR agonists, LG 101506's unique structure, (2E,4E,6Z)-7-(3,5-di-tert-butyl-2-(2,2-difluoroethoxy)phenyl)-3-methylocta-2,4,6-trienoic acid, provides selectivity and stability, minimizing off-target effects in nuclear receptor crosstalk studies.

Evidence & Benchmarks

• LG 101506 exhibits 98% chemical purity by HPLC under standard conditions (APExBIO certificate of analysis: product B7414).
• Solubility parameters: 42.05 mg/ml in DMSO and 21.03 mg/ml in ethanol at 25°C (APExBIO datasheet).
• Storage at -20°C preserves stability for >12 months as an off-white solid; solutions should be freshly prepared due to potential degradation (manufacturer guidelines).
• RXR signaling modulates PD-L1 stability via post-translational and transcriptional mechanisms, impacting immune checkpoint blockade efficacy in models of triple-negative breast cancer (Zhang et al. 2022, DOI).
• RXR modulation is essential for dissecting metabolism regulation and immune resistance in cancer, as demonstrated in translational research on nuclear receptor-related disease models (Strategic RXR Modulation).
• LG 101506's defined profile supports reproducible workflows for RXR target validation and pathway dissection, complementing conventional RXR ligands (Advanced RXR Modulator Applications).

Applications, Limits & Misconceptions

LG 101506 is intended for in vitro and in vivo RXR signaling pathway research, including:

• Mapping transcriptional networks regulated by RXR in metabolism and immunity.
• Modeling nuclear receptor-related diseases, including metabolic syndrome and cancer.
• Examining RXR's role in immune checkpoint regulation and tumor microenvironment adaptation.
• Benchmarking RXR ligand specificity in chemical biology and pharmacology studies.

Compared to Next-Generation RXR Modulators, this article emphasizes atomic purity, solubility, and workflow reproducibility for experimental controls and standardization.

Common Pitfalls or Misconceptions

• LG 101506 is not a therapeutic or diagnostic agent; it is for research use only (APExBIO).
• Long-term storage of LG 101506 solutions is not recommended due to degradation risks; solids should be stored at -20°C.
• The compound does not modulate all nuclear receptors; its action is selective for RXR and RXR-containing heterodimers.
• Results from RXR modulation may not extrapolate directly to clinical outcomes; further validation in disease models is required (Zhang et al. 2022).
• Solubility parameters must be respected to avoid precipitation or inaccurate dosing in assays.

Workflow Integration & Parameters

LG 101506 is supplied as an off-white solid in aliquots suitable for research-scale experiments. For solution preparation, dissolve up to 42.05 mg/ml in DMSO or 21.03 mg/ml in ethanol at ambient temperature (25°C), ensuring immediate use or aliquoting to avoid repeated freeze-thaw cycles. The compound is shipped by APExBIO on blue ice for small molecules or dry ice for modified nucleotides, ensuring integrity during transit. For RXR signaling studies, typical concentrations range from 0.1 to 10 μM, adjusted per assay sensitivity and cell type. It is compatible with both cell-based and cell-free assays for nuclear receptor biology. Data reporting should reference the specific batch, matrix, and time of preparation to ensure reproducibility. This guide offers more granular workflow details than the summary found in A High-Purity RXR Modulator for Advanced Nuclear Receptor Research.

Conclusion & Outlook

LG 101506 (APExBIO, B7414) represents a robust, high-purity standard for RXR signaling pathway research. Its defined chemical profile, solubility, and storage parameters facilitate rigorous nuclear receptor investigations. By enabling precise dissection of RXR-mediated transcriptional and immunological processes, LG 101506 advances the field of metabolism regulation and cancer immunology. Continued integration in translational workflows will help clarify RXR's role in disease and support the development of next-generation nuclear receptor modulators. For ordering and further documentation, see the LG 101506 product page.